Baker Street Capital Closes Entire Unilens Stake in Buyback

Baker Street Capital, Unilens Vision: In an amended 13D filed moments ago with the SEC, activist Baker Street Capital reported that it has closed its position in Unilens Vision (OTC:UVIC). The contract lens maker reported last week that it was initiating a stock buyback worth 26% of its company. Baker Street’s stake represented a little over $3 million in the micro-cap.

SC_unilens_logo

In a statement, Unilens Vision disclosed that it has repurchased 618,522 shares from Baker Street Capital, which was the largest outside shareholder of the company. The price offered in the buyback was $4.97 per share. At the same time, Unilens stated that one of the directors of the company Vadim Perelman resigned. Perelman was a founder, managing partner and Chief Investment Officer at Baker Street.

Unilens posted a net income of $128,960 in the previous quarter, which shows a 46% decline on a year-over-year basis. Diluted EPS of the company fell to $0.05, versus $0.10 in the same period of last year.

Disclosure: none

Recommended Reading:

BlueMountain Increases Activist Stake in Eastman Kodak to 20% of Company

Why Investing Like This Activist Could Make You Look Smart

How to Play Merger Arbitrage Cliff Asness Style

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!